VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISHL12 2022 | The use of TARC as a diagnostic biomarker in Hodgkin lymphoma

Arjan Diepstra, PhD, University of Groningen, Groningen, The Netherlands, shares some insights into why the thymus and activation-regulated chemokine (TARC) protein is an attractive biomarker in Hodgkin lymphoma (HL), highlighting that this protein is an important promoter of Hodgkin Reed-Sternberg cell growth, and is present at high levels in serum making it easily measurable. This interview took place at the 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter